Mitochondrial Medicine at Children’s Hospital of Philadelphia (CHOP) is emerging as the premiere center in the world for multidisciplinary clinical care, advanced diagnostics and therapies, and individualized basic, translational, and clinical research programs dedicated to improving the health of patients of all ages living with mitochondrial disease. The program is part of the Division of Human Genetics.
The Frontier Programs are unique, cutting-edge programs that will forge important new discoveries, deliver novel therapies, and help children and adults thrive.
Please join us for an informational session to guide your visit and care through the CHOP Mitochondrial Medicine Program. Dr. Amy Goldstein, the Clinical Director, and Genetic Counselor James Peterson will answer your questions.
What is Mitochondrial Myopathy? my·op·a·thy mīˈäpəTHē/ The word “myopathy” means disease of the muscle tissue. As the term implies, mitochondrial myopathy (MM) is a...
Mitoaction discussion dealing with holiday stress and the importance of watching fluid intake.
